Renaissance Capital logo

Drug developer Voyager Pharmaceutical cuts offering size, range

December 8, 2005

Voyager Pharmaceutical, a developer of drugs for diseases associated with aging and development, particularly Alzheimer's, reduced its offering size -24% to 4.5 million shares from 5.9 million and likewise sliced its range -24% to $11-$15 from $15-$19. Sole underwriter WR Hambrecht plans to conduct a Dutch auction IPO tonight. Expect the stock to begin trading Friday morning on the NASDAQ under the symbol "VYGR."